Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 353

    1.

    Oral contraceptives, angiotensin-dependent renal vasoconstriction, and risk of diabetic nephropathy.

    Ahmed SB, Hovind P, Parving HH, Rossing P, Price DA, Laffel LM, Lansang MC, Stevanovic R, Fisher ND, Hollenberg NK.

    Diabetes Care. 2005 Aug;28(8):1988-94.PMID: 16043743 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    The effect of oral contraceptives on the nitric oxide system and renal function.

    Cherney DZ, Scholey JW, Cattran DC, Kang AK, Zimpelmann J, Kennedy C, Lai V, Burns KD, Miller JA.

    Am J Physiol Renal Physiol. 2007 Nov;293(5):F1539-44. Epub 2007 Aug 22.PMID: 17715260 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Glomerular hemodynamics and the renin-angiotensin system in patients with type 1 diabetes mellitus.

    Hollenberg NK, Price DA, Fisher ND, Lansang MC, Perkins B, Gordon MS, Williams GH, Laffel LM.

    Kidney Int. 2003 Jan;63(1):172-8.PMID: 12472780 [PubMed - indexed for MEDLINE]Related articles

    4.

    Effect of oral contraceptives on the renin angiotensin system and renal function.

    Kang AK, Duncan JA, Cattran DC, Floras JS, Lai V, Scholey JW, Miller JA.

    Am J Physiol Regul Integr Comp Physiol. 2001 Mar;280(3):R807-13.PMID: 11171661 [PubMed - indexed for MEDLINE]Related articles

    5.

    Oral contraceptive progestins and angiotensin-dependent control of the renal circulation in humans.

    Sarna MA, Hollenberg NK, Seely EW, Ahmed SB.

    J Hum Hypertens. 2009 Jun;23(6):407-14. Epub 2009 Jan 22.PMID: 19158821 [PubMed - indexed for MEDLINE]Related articles

    6.

    A study of the interactive effects of oral contraceptive use and dietary fat intake on blood pressure, cardiovascular reactivity and glucose tolerance in normotensive women.

    Straznicky NE, Barrington VE, Branley P, Louis WJ.

    J Hypertens. 1998 Mar;16(3):357-68.PMID: 9557929 [PubMed - indexed for MEDLINE]Related articles

    7.

    Renin release in response to Renin system blockade: activation of the Renin system in type 1 diabetes mellitus.

    Stevanovic RD, Price DA, Lansang MC, Fisher ND, Laffel LM, Hollenberg NK.

    J Renin Angiotensin Aldosterone Syst. 2005 Sep;6(2):78-83.PMID: 16470486 [PubMed - indexed for MEDLINE]Related articles

    8.

    Renal characteristics and effect of angiotensin suppression in oral contraceptive users.

    Ribstein J, Halimi JM, du Cailar G, Mimran A.

    Hypertension. 1999 Jan;33(1):90-5.PMID: 9931087 [PubMed - indexed for MEDLINE]Related articlesFree article

    10.

    Renal and hormonal responses to direct renin inhibition with aliskiren in healthy humans.

    Fisher ND, Jan Danser AH, Nussberger J, Dole WP, Hollenberg NK.

    Circulation. 2008 Jun 24;117(25):3199-205. Epub 2008 Jun 16.PMID: 18559696 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    ACE and non-ACE pathways in the renal vascular response to RAS interruption in type 1 diabetes mellitus.

    Lansang MC, Stevanovic R, Price DA, Laffel LM, Hollenberg NK.

    Kidney Int. 2005 Mar;67(3):1033-7.PMID: 15698442 [PubMed - indexed for MEDLINE]Related articles

    12.

    Renal functional reserve in IDDM patients.

    Sackmann H, Tran-Van T, Tack I, Hanaire-Broutin H, Tauber JP, Ader JL.

    Diabetologia. 1998 Jan;41(1):86-93.PMID: 9498635 [PubMed - indexed for MEDLINE]Related articles

    13.

    Hyperglycemia and angiotensin-mediated control of the renal circulation in healthy humans.

    Osei SY, Price DA, Fisher ND, Porter L, Laffel LM, Hollenberg NK.

    Hypertension. 1999 Jan;33(1 Pt 2):559-64.PMID: 9931165 [PubMed - indexed for MEDLINE]Related articlesFree article

    14.

    Intrarenal hemodynamic changes after captopril test in patients with type 2 diabetes: a duplex Doppler sonography study.

    Taniwaki H, Ishimura E, Kawagishi T, Matsumoto N, Hosoi M, Emoto M, Shoji T, Shoji S, Nakatani T, Inaba M, Nishizawa Y.

    Diabetes Care. 2003 Jan;26(1):132-7.PMID: 12502669 [PubMed - indexed for MEDLINE]Related articlesFree article

    15.

    Renal functional response to protein loading in type 1 (insulin-dependent) diabetic patients on normal or high salt intake.

    Lopes de Faria JB, Friedman R, de Cosmo S, Dodds RA, Mortton JJ, Viberti GC.

    Nephron. 1997;76(4):411-7.PMID: 9274838 [PubMed - indexed for MEDLINE]Related articles

    16.

    Impact of hyperglycemia on the renin angiotensin system in early human type 1 diabetes mellitus.

    Miller JA.

    J Am Soc Nephrol. 1999 Aug;10(8):1778-85.PMID: 10446946 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Prorenin and angiotensin-dependent renal vasoconstriction in type 1 and type 2 diabetes.

    Stankovic AR, Fisher ND, Hollenberg NK.

    J Am Soc Nephrol. 2006 Dec;17(12):3293-9. Epub 2006 Nov 8.PMID: 17093063 [PubMed - indexed for MEDLINE]Related articlesFree article

    18.

    Type 2 diabetes, obesity, and the renal response to blocking the renin system with irbesartan.

    Price DA, Lansang MC, Osei SY, Fisher ND, Laffel LM, Hollenberg NK.

    Diabet Med. 2002 Oct;19(10):858-61.PMID: 12358875 [PubMed - indexed for MEDLINE]Related articles

    19.

    Angiotensin II type 1 receptor gene polymorphism and the response to hyperglycemia in early type 1 diabetes.

    Miller JA, Thai K, Scholey JW.

    Diabetes. 2000 Sep;49(9):1585-9.PMID: 10969844 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate.

    Schjoedt KJ, Andersen S, Rossing P, Tarnow L, Parving HH.

    Diabetologia. 2004 Nov;47(11):1936-9. Epub 2004 Nov 17.PMID: 15551047 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data